ArticleOncotarget2016
Landscape of activating cancer mutations in FGFR kinases and their differential responses to inhibitors in clinical use.
Harshnira Patani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
57 papers cite it
this papercites it